| Trial ID: | L4705 |
| Source ID: | NCT01051102
|
| Associated Drug: |
Insulin Degludec/Insulin Aspart
|
| Title: |
Effect of NN5401 in Japanese Subjects With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: insulin degludec/insulin aspart|DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: Area under the Glucose Infusion Rate curve after a single dose, From 4-12 hours | Secondary: Area under the insulin aspart concentration-time curve after a single dose, From 0-12 hours
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-01
|
| Completion Date: |
2010-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-10
|
| Locations: |
Novo Nordisk Investigational Site, Tokyo, 130-0004, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01051102
|
